
VERV
NGSVerve Therapeutics Inc.
Professional, Scientific, and Technical Services•Research and Development in Biotechnology
Watchlists:
Last updated: Friday 18th July 2025
10.95
-0.07 (-0.64%)
Prev Close:11.02
Open:11.01
Bid:10.95
Ask:11.0
52 Week Range
2.8711.41
Volume:4,607,812
Mkt Cap:982 M
61
MarketXLS Rank ®
Buy
Price Target
$12.59
+15.0%
PE Ratio (TTM)
LiveReturns the ratio of the stock's current price to its Earnings Per Share (EPS) for the past 12 months.
How calculated | It is calculated by dividing current share price to its EPS for one year |
Example usage | =PERatio("MSFT") |
Notes | Higher the PE number, higher the valuation company is receiving |
Assets | Stocks |